ENDOGENE INVESTOR CENTRE
INVESTOR CENTRE
Endogene Ltd. is an unlisted Australian public company. To date, the company has been funded by a Biotechnology Innovation Fund grant, an Australian Export Market Development grant, R&D tax concession funds and by private investors who share our vision and have understood the potential of our core technologies to improve the lives of millions of people around the world.
We have provided this section of our web site to enable current and future prospective investors access to information on our progress in fulfillment of our mission in bringing our products to the global market.
For further information on the benefits of investing in Endogene today, click here to contact us.
We have provided this section of our web site to enable current and future prospective investors access to information on our progress in fulfillment of our mission in bringing our products to the global market.
For further information on the benefits of investing in Endogene today, click here to contact us.
EMAIL ALERTSYou can subscribe to Endogene news through our email alerts.
Please complete this form to join Endogene email alerts. The information you provide will be handled in accordance with our Privacy Policy. You may cancel Email Alerts at any time by request. Simply resubmit the form with the word REMOVE in the Comment section. SOCIAL MEDIA ALERTS
|
|
**Disclaimer: The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Any product information detailed on this website should be considered in the context of our standard Terms of Use document below. The information on this website may contain forward-looking statements that are based on management’s beliefs, assumptions and expectations and on information currently available to management. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to our ability to commercialize any or all of the products described on this site, including our estimates of potential revenues, costs, profitability and financial performance, our ability to obtain reimbursement for our products; our expectations with respect to clinical trials of the products, including completion of our clinical trials and our associated regulatory submissions and approvals; our expectations with respect to the integrity of our intellectual property assets. Management believes that these forward-looking statements are reasonable as of the time they are made. You should not place undue reliance on forward-looking statements as they speak only as of the time when made. Endogene Ltd. does not assume any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Endogene Ltd. or its subsidiaries may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events could differ materially from those disclosed in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties. Endogene Ltd. disclaims all and any guarantees, undertakings and warranties, expressed or implied, and shall not be liable for any loss or damage whatsoever (including human or computer error, negligent or otherwise, or incidental or consequential loss or damage) arising out of or in connection with any use or reliance on the information or advice on this site. The user must accept sole responsibility associated with the use of the material on this site, irrespective of the purpose for which such use or results are applied. The information on this website is not a substitute for advice from a qualified independent financial adviser.